Cardinal Health Inc. (NYSE:CAH) saw a downside of -0.75% to $88.00 after subtracting -$0.67 on Wednesday. The 5-day average trading volume is 1,435,867 shares of the company’s common stock. It has gained $89.92 in the past week and touched a new high 1 time within the past 5 days. An average of 1,875,532 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,166,709.
CAH’s 1-month performance is -1.93% or $0.33 on its low of $86.56 reached on 09/05/23. The company’s shares have touched a 52-week low of $65.53 and high of $95.45, with the stock’s rally to the 52-week high happening on 08/15/23. YTD, CAH has achieved 14.49% or $11.09 and has reached a new high 29 times. However, the current price is down -7.80% from the 52-week high price.
Insider Transactions
CAH stock investors last saw insider trading activity on Aug 28.WEITZMAN DEBORAH (CEO, Pharmaceutical Segment) most recently sold 6,712 shares at $89.81 per share on Aug 28. This transaction cost the insider $602,805. Chief Accounting Officer, Scherer Mary C., sold 20,695 shares at a price of $86.27 on Aug 18. Then, on Aug 17, CEO, Medical Segment Mason Stephen M sold 37,500 shares at a price of $87.32 per share. This transaction amounted to $3,274,642.
Valuation Metrics
CAH stock has a beta of 0.78. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.11 while the price to cash flow ratio at 9.36.
Cardinal Health Inc.’s quick ratio for the period ended June 29 was 0.53, with the current ratio over the same period at 1.00. In terms of profitability, the gross margin trailing 12 months is 3.26%. The firm’s gross profit as reported stood at $6.89 billion against revenue of $205.01 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 315.62% to -$64.0 million, while revenue of $345.0 million was 639.06% off the previous quarter. Analysts expected CAH to announce $1.49 per share in earnings in its latest quarter, but it posted $1.55, representing a 4.00% surprise. EBITDA for the quarter stood at more than $313.0 million. CAH stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 46.27 billion, with total debt at $5.27 billion. Shareholders hold equity totaling $250.68 million.
Let’s look briefly at Cardinal Health Inc. (CAH) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 26 September was 43.32% to suggest the stock is trending Neutral, with historical volatility in this time period at 9.29%.
The stock’s 5-day moving average is $88.78, reflecting a -1.57% or -$1.41 change from its current price. CAH is currently trading -2.08% above its 20-day SMA, +8.83% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -5.61% and SMA200 by+8.89%.
Stochastic %K and %D was 56.01% and 66.72% and the average true range (ATR) pointed at 1.30. The RSI (14) points at 45.31%, while the 14-day stochastic is at 32.60% with the period’s ATR at 1.34. The stock’s 9-day MACD Oscillator is pointing at 0.01 and 0.00 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Cardinal Health Inc. (NYSE: CAH), Evercore ISI downgraded it to an In-line rating. They previously had an Outperform rating on the stock. Analysts offering their rating for CAH stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate CAH as a “sell,”, while 9 advise that investors “Hold.” 1 analysts have rated the stock as underweight. 1 rates the stock as overweight while 3 have offered a “buy” rating.
What is CAH’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $78.70 and a high of $108.00, with their median price target at $100.00. Looking at these predictions, the average price target given by analysts is for Cardinal Health Inc. (CAH) stock is $98.14.
